Regulation of telomeres length: Getting access to telomeres;Régulation de la longueur des télomères: Rendre le télomère accessible?

Bulletin du Cancer

Volumn 92, Issue 1, 2005, Pages 13-22

  Riou, Jean François ^a   Gomez, Dennis ^a,b   Mergny, Jean Louis ^b   Guittat, Lionel ^b   Paterski, Rajaa ^a   Chenais, Benoît ^a   Morjani, Hamid ^a   Trentesaux, Chantal ^a  

^a UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^b CNRS   (France)

Author keywords

Chromosome; Chromosomic instability; DNA binding protein; G quadruplex; Telomerase; Telomere; Telomeric overhang

Indexed keywords

DNA BINDING PROTEIN; POLY(ADENOSINE DIPHOSPHATE RIBOSE); TELOMERASE;

CELL PROLIFERATION; CHROMOSOMAL INSTABILITY; CHROMOSOME ANALYSIS; CHROMOSOME SIZE; CHROMOSOME STRUCTURE; ENZYME STRUCTURE; GENETIC STABILITY; HUMAN; REVIEW; TELOMERE;

CELL DIVISION; DNA HELICASES; DNA REPLICATION; GENOMIC INSTABILITY; HUMANS; REPETITIVE SEQUENCES, NUCLEIC ACID; TELOMERASE; TELOMERE; TELOMERIC REPEAT BINDING PROTEIN 1; TELOMERIC REPEAT BINDING PROTEIN 2;

EID: 13844275375     PISSN: 00074551     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (59)

1. McClintock B. The behavior in successive nuclear divisions of a chromosome broken at meiosis. Proc Natl Acad Sci USA 1939; 25: 405-16.
2. Stewart SA, Weinberg RA. Telomerase and human tumorigenesis. Semin Cancer Biol 2000; 10: 399-406.
3. McEachern MJ, Krauskopf A, Blackburn EH. Telomeres and their control. Annu Rev Genet 2000; 34: 331-58.
4. Lavelle F, Riou JF, Laoui A, Mailliet P. Telomerase: a therapeutic target for the third millennium? Crit Rev Oncol Hematol 2000; 34: 111-26.
5. Mergny JL, Mailliet P, Lavelle F, Riou JF, Laoui A, Helene C. The development of telomerase inhibitors: the G-quartet approach. Anticancer Drug Des 1999; 14: 327-39.
6. Mergny JL, Riou JF, Mailliet P, Teulade-Fichou MP, Gilson E. Natural and pharmacological regulation of telomerase. Nucleic Acids Res 2002; 30: 839-65.
7. Smogorzewska A, De Lange T. Regulation of telomerase by telomeric proteins. Annu Rev Biochem 2004; 73: 177-208.
8. Blackburn EH. Switching and signaling at the telomere. Cell 2001; 106: 661-73.
9. Neumann AA, Reddel RR. Telomere maintenance and cancer: look, no telomerase. Nature Rev Cancer 2002; 2: 879-84.
10. Smith S, de Lange T. TRF1, a mammalian telomeric protein. Trends Genet 1997; 13: 21-6.
11. Bilaud T, Brun C, Ancelin K, Koering CE, Laroche T, Gilson E. Telomeric localization of TRF2, a novel human telobox protein. Nature Genet 1997; 17: 236-9.
12. Henderson ER, Blackburn EH. An overhanging 3′ terminus is a conserved feature of telomeres. Mol Cell Biol 1989; 9: 345-8.
13. Smogorzewska A, Van Steensel B, Bianchi A, et al. Control of human telomere length by TRF1 and TRF2. Mol Cell Biol 2000; 20: 1659-68.
14. Griffith JD, Comeau L, Rosenfield S, et al. Mammalian telomeres end in a large duplex loop. Cell 1999; 97: 503-14.
15. Zahler AM, Williamson JR, Cech TR, Prescott D. M. Inhibition of telomerase by G-quartet DNA structures. Nature 1991; 350: 718-20.
16. de Lange T. T-loops and the origin of telomeres. Nature Rev Mol Cell Biol 2004; 5: 323-9.
17. Stansel RM, de Lange T, Griffith JD. T-loop assembly in vitro involves binding of TRF2 near the 3′ telomeric overhang. EMBO J 2001; 20: 5532-40.
18. Zhu XD, Niedernhofer L, Kuster B, Mann M, Hoeijmakers JH, de Lange T. ERCC1/XPF removes the 3′ overhang from uncapped telomeres and represses formation of telomeric DNA-containing double minute chromosomes. Mol Cell 2003; 12: 1489-98.
19. Khakhar RR, Cobb JA, Bjergbaek L, Hickson ID, Gasser SM, Wu L. RecQ helicases: multiple roles in genome maintenance. Trends Cell Biol 2003; 13: 493-501.
20. Davies JT. G-quartet 40 years later: from 5′-GMP to molecular biology and supramolecular chemistry. Angew Chem Int Ed Engl 2004; 43: 668-98.
21. Mills M, Lactoix L, Arimondo PB, et al. Unusual DNA conformations: implications for telomeres. Curr Med Chem Anti-Canc Agents 2002; 2: 627-44.
22. Neidle S, Parkinson GN. The structure of telomeric DNA. Curr Opin Struct Biol 2003; 13: 275-83.
23. Riou JF, Gomez D, Lemarteleur T, Trentesaux C. G-quadruplex DNA: myth or reality? Bull Cancer 2005; 90: 305-13.
24. Gomez D, Paterski R, Lemarteleur T, Shin-Ya K, Mergny JL, Riou JF. Interaction of telomestatin with the telomeric single-strand overhang. J Biol Chem 2004; 279: 41487-94.
25. Ding H, Schertzer M, Wu X, et al. Regulation of murine telomere length by Rtel: an essential gene encoding a helicase-like protein. Cell 2004; 117: 873-86.
26. Cheung I, Schertzer M, Rose A, Lansdorp PM. Disruption of dog-1 in Caenorhabditis elegans triggers deletions upstream of guanine-rich DNA. Nature Genet 2002; 31: 405-9.
27. Duquette ML, Handa P, Vincent JA, Taylor AF, Maizels N. Intracellular transcription of G-rich DNAs induces formation of G-loops, novel structures containing G4 DNA. Genes Dev 2004; 18: 1618-29.
28. Lillard-Wetherell K, Machwe A, Langland GT, et al. Association and regulation of the BLM helicase by the telomere proteins TRF1 and TRF2. Hum Mol Genet 2004; 13: 1919-32.
29. Stavropoulos DJ, Bradshaw PS, Li X, et al. The Bloom syndrome helicase BLM interacts with TRF2 in ALT cells and promotes telomeric DNA synthesis. Hum Mol Genet 2002; 11: 3135-44.
30. Opresko PL, Von Kobbe C, Laine JP, Harrigan J, Hickson ID, Bohr VA. Telomere-binding protein TRF2 binds to and stimulates the Werner and Bloom syndrome helicases. J Biol Chem 2002; 277: 41110-9.
31. Du X,Shen J, Kugan N, et al. Telomere shortening exposes functions for the mouse werner and bloom syndrome genes. Mol Cell Biol 2004; 24: 8437-46.
32. Opresko PL, Otterlei M, Graakjaer J, et al. The Werner syndrome helicase and exonuclease cooperate to resolve telomeric D loops in a manner regulated by TRF1 and TRF2. Mol Cell 2004; 14: 763-74.
33. Marcand S, Gilson E. Shore DA protein-counting mechanism for telomere length regulation in yeast. Science 1997; 275: 986-90.
34. Hemann MT, Strong MA, Hao LY, Greider CW. The shortest telomere, not average telomere length, is critical for cell viability and chromosome stability. Cell 2001; 107: 67-77.
35. Teixeira MT, Arnetic M, Sperisen P, Lingner J. Telomere length homeostasis is achieved via a switch between telomerase- extendible and -nonextendible states. Cell 2004; 117: 323-35.
36. Wotton D. Shore DA novel Rap1p-interacting factor, Rif2p, cooperates with Rif1p to regulate telomere length in Saccharomyces cerevisiae. Genes Dev 1997; 11: 748-60.
37. Van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end-to-end fusions. Cell 1998; 92: 401-13.
38. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999; 283: 1321-5.
39. Harrington L. Those dam-aged telomeres! Curr Opin Genet Dev 2004; 14: 22-8.
40. Karlseder J, Smogorzewska A, de Lange T. Senescence induced by altered telomere state, not telomere loss. Science 2002; 295: 2446-9.
41. Van Steensel B, de Lange T. Control of telomere length by the human telomeric protein TRF1. Nature 1997; 385: 740-3.
42. Kim SH, Kaminker P, Campisi J. TIN2, a new regulator of telomere length in human cells. Nature Genet 1999; 23: 405-12.
43. Smith S, Giriat I, Schmitt A, de Lange T. Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998; 282: 1484-7.
44. Ye JZ, de Lange T. TIN2 is a tankyrase 1 PARP modulator in the TRF1 telomere length control complex. Nature Genet 2004; 36: 618-23.
45. Dantzer F, Giraud-Panis MJ, Jaco I, et al. Functional interaction between poly(ADP-ribose) polymerase 2 (PARP-2) and TRF2: PARP activity negatively regulates TRF2. Mol Cell Biol 2004; 24: 1595-607.
46. Baumann P, Cech TR. Pot1, the putative telomere end-binding protein in fission yeast and humans. Science 2001; 292: 1171-5.
47. Pitt CW, Moreau E, Lunness PA, Doonan JH. The pot1+ homologue in Aspergillus nidulans is required for ordering mitotic events. J Cell Sci 2004; 117: 199-209.
48. Colgin LM, Baran K, Baumann P, Cech TR, Reddel RR. Human POT1 facilitates telomere elongation by Telomerase. Curr Biol 2003; 13: 942-6.
49. Loayza D, De Lange T. POT1 as a terminal transducer of TRF1 telomere length control. Nature 2003; 23: 1013-8.
50. Ye JZ, Hockemeyer D, Krutchinsky AN, et al. POT1-interacting protein PIP1: a telomere length regulator that recruits POT1 to the TIN2/TRF1 complex. Genes Dev 2004; 18: 1649-54.
51. Liu D, Safari A, O'Connor MS, et al. PTOP interacts with POT1 and regulates its localization to telomeres. Nature Cell Biol 2004; 6: 673-80.
52. Houghtaling BR, Cuttonaro L, Chang W, Smith SA. Dynamic molecular link between the telomere length regulator TRF1 and the chromosome end protector TRF2. Curr Biol 2004; 14: 1621-31.
53. Ye JZ, Donigian JR, Van Overbeek M, et al. TIN2 binds TRF1 and TRF2 simultaneously and stabilizes the TRF2 complex on telomeres. J Biol Chem 2004; 279: 47264-71.
54. Kim SH, Beausejour C, Davalos AR, Kaminker P, Heo SJ, Campisi J. TIN2 mediates functions of TRF2 at human telomeres. J Biol Chem 2004; 279: 43799-804.
55. Liu D, O'Connor MS, Qin J, Songyang Z. Telosome: a mammalian telomere associated complex formed by multiple telomeric proteins. J Biol Chem 2004; 279: 51338-42.
56. Karlseder J, Kachatrian L, Takai H, et al. Targeted deletion reveals an essential function for the telomere length regulator Trf1. Mol Cell Biol 2003; 23: 6533-41.
57. Chiang YJ, Kim SH, Tessarollo L, Campisi J, Hodes RJ. Telomere-associated protein TIN2 is essential for early embryonic development through a telomerase-independent pathway. Mol Cell Biol 2004; 24: 6631-4.
58. Lei M, Baumann P, Cech TR. Cooperative binding of single-stranded telomeric DNA by the Pot1 protein of Schizosaccharomyces pombe. Biochemistry 2002; 41: 14560-8.
59. Lustig AJ. Cdc13 subcomplexes regulate multiple telomere functions. Nature Struct Biol 2001; 8: 297-9.